You are currently viewing Osteonecrose medicamentosa: o que o implantodontista deve saber: parte 1

Osteonecrose medicamentosa: o que o implantodontista deve saber: parte 1

Referencias

  • Eguia, A.; Bagán-Debón, L.; Cardona, F. Review and update on drugs related to the development of osteonecrosis of the jaw.Med. Oral Patología Oral y Cirugia Bucal 2020, 25, e71–e83. [CrossRef] [PubMed].
  • https://www.who.int/pt/about, https://www.osteoporosis.foundation
  • Sacco R, Woolley J, Patel G, Calasans-Maia MD, Yates J. Systematic review of medication related osteonecrosis of the jaw (MRONJ) in patients undergoing only antiangiogenic drug therapy: surgery or conservative therapy? Br J Oral Maxillofac Surg. 2022 Feb;60(2):e216-e230. doi: 10.1016/j.bjoms.2021.03.006. Epub 2021 Mar 24. PMID: 35115201.
  • Beth-Tasdogan NH, Mayer B, Hussein H, Zolk O, Peter JU. Interventions for managing medication-related osteonecrosis of the jaw. Cochrane Database Syst Rev. 2022 Jul 12;7(7):CD012432. doi: 10.1002/14651858.CD012432.pub3. PMID: 35866376; PMCID: PMC9309005.
  • Ruggiero SL, Dodson TB, Aghaloo T, Carlson ER, Ward BB, Kademani D. American Association of Oral and Maxillofacial Surgeons’ Position Paper on Medication-Related Osteonecrosis of the Jaws—2022 Update. Journal of Oral and Maxillofacial Surgery [Internet]. 2022;80(5):920–43.
  • Ruggiero, S.L.; Dodson, T.B.; Fantasia, J.; Goodday, R.; Aghaloo, T.; Mehrotra, B.; O’Ryan, F. American Association of Oral and Maxillofacial Surgeons position paper on medication-related osteonecrosis of the jaw—2014 update. J. Oral. Maxillofac. Surg. 2014, 72, 1938–1956].
  • Shibahara T. Antiresorptive Agent-Related Osteonecrosis of the Jaw (ARONJ): A Twist of Fate in the Bone. Tohoku J Exp Med. 2019 Feb;247(2):75-86. doi: 10.1620/tjem.247.75. PMID: 30713280.
  • Migliorati CA, Schubert MM, Peterson DE, Seneda LM. Bisphosphonate-associated osteonecrosis of mandibular and maxillary bone: an emerging oral complication of supportive cancer therapy. Cancer. 2005 Jul 1;104(1):83-93. doi: 10.1002/cncr.21130. PMID: 15929121.
  • Junquera L, Gallego L. Nonexposed bisphosphonate-related osteonecrosis of the jaws: another clinical variant? J Oral Maxillofac Surg. 2008 Jul;66(7):1516-7. doi: 10.1016/j.joms.2008.02.012. PMID: 18571043.
  • Bianchi SD, Scoletta M, Cassione FB, Migliaretti G, Mozzati M. Computerized tomographic findings in bisphosphonate-associated osteonecrosis of the jaw in patients with cancer. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2007 Aug;104(2):249-58. doi: 10.1016/j.tripleo.2007.01.040.
  • Arce K, Assael LA, Weissman JL, Markiewicz MR. Imaging findings in bisphosphonate-related osteonecrosis of jáws. J Oral Maxillofac Surg. 2009 May;67(5 Suppl):75-84. doi: 10.1016/j.joms.2008.12.002. PMID: 19371818.

Momesso GAC, Lemos CAA, Santiago-J.nior JF, Faverani LP, Pellizzer EP. Laser surgery in management of medication-related osteonecrosis of the jaws: a meta-analysis. Oral Maxillofac Surg 2020;24(2):133-44.

  • Ervolino E, Statkievicz C, Toro LF, de Mello-Neto JM, Cavazana TP, Issa JPM et al. Antimicrobial photodynamic therapy improves the alveolar repair process and prevents the occurrence of osteonecrosis of the jaws after tooth extraction in senile rats treated with zoledronate. Bone 2019;120:101-13.

 

 

Tags: , , ,